General
Preferred name
MEDROXYPROGESTERONE ACETATE
Synonyms
MPA ()
Medroxyprogesterone (acetate) ()
Medroxyprogesterone 17-acetate ()
Farlutin ()
NSC-26386 ()
Metigestrona ()
Provera ()
medroxyprogesterone ()
Medroxyprogesterone (acetate)Medroxyprogesterone 17-acetate ()
Medroxyprogesterone acetate (NSC-26386) ()
MPA, NSC-26386, Medroxyprogesterone 17-acetate, Farlutin ()
Sayana Press ()
Depo-Provera ()
Cycrin ()
Medroxiprogesterone Acetate ()
Farlutal 250 ()
Adgyn Medro ()
Medroxyprogesteroni acetas ()
NSC-21171 ()
Farlutal ()
NSC-27408 ()
Depo-Progevera ()
Farlutal inyectable ()
Medroxyprogesterone ()
Curretab ()
Prempro ()
Farlutal 500 ()
TV-46046 ()
Depo-Subq Provera 104 ()
Farlutal 100 ()
Farlutal 200 ()
Depot-medroxyprogesterone acetate ()
Lunelle ()
Amen ()
Climanor ()
G03AC06 ()
Depo-Provera Oncology ()
P&D ID
PD003108
CAS
71-58-9
135843-32-2
Tags
natural product
drug
available
Approved by
FDA
First approval
1959
Drug Status
investigational
approved
Max Phase
Phase 4
Drug indication
Progestin
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
5
Organisms
0
Compound Sets
17
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
EU-OPENSCREEN Bioactive Compound Library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NIH Clinical Collections (NCC)
NPC Screening Collection
NURSA ligand set
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
42
Properties
(calculated by RDKit )
Molecular Weight
386.25
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
0
Rotatable Bonds
2
Ring Count
4
Aromatic Ring Count
0
cLogP
4.66
TPSA
60.44
Fraction CSP3
0.79
Chiral centers
7.0
Largest ring
6.0
QED
0.65
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Endocrinology/Hormones
Immunology/Inflammation
Metabolic Enzyme/Protease
Vitamin D Related/Nuclear Receptor
Target
ER
PR
ESR1, PGR
Androgen Receptor
Endogenous Metabolite
Glucocorticoid Receptor
Progesterone Receptor
Estrogen/progestogen Receptor
Indication
contraceptive
MOA
Progesterone receptor agonist
Source data
